Cargando…
Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk
OBJECTIVES: To assess the effect of preventive pravastatin treatment on coronary heart disease (CHD) morbidity and mortality in older persons at risk for cardiovascular disease (CVD), stratified according to plasma levels of homocysteine. DESIGN: A post hoc subanalysis in the PROspective Study of Pr...
Autores principales: | Drewes, Yvonne M, Poortvliet, Rosalinde K E, Blom, Jeanet W, de Ruijter, Wouter, Westendorp, Rudi G J, Stott, David J, Blom, Henk J, Ford, Ian, Sattar, Naveed, Wouter Jukema, J, Assendelft, Willem J J, de Craen, Anton J M, Gussekloo, Jacobijn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232895/ https://www.ncbi.nlm.nih.gov/pubmed/24447238 http://dx.doi.org/10.1111/jgs.12660 |
Ejemplares similares
-
Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
por: Poortvliet, Rosalinde K. E., et al.
Publicado: (2012) -
Prognostic value of cardiovascular disease status: the Leiden 85-plus study
por: van Peet, Petra G., et al.
Publicado: (2012) -
Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study
por: de Ruijter, Wouter, et al.
Publicado: (2009) -
Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
por: Lloyd, Suzanne M., et al.
Publicado: (2013) -
Genome-Wide Study of Gene Variants Associated with Differential Cardiovascular Event Reduction by Pravastatin Therapy
por: Shiffman, Dov, et al.
Publicado: (2012)